Metropolitan Life Insurance Company (MetLife)’s Synaptics SYNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,075
| Closed | -$202K | – | 1880 |
|
|
2024
Q1 | $202K | Sell |
2,075
-166
| -7% | -$17.4K | 0.01% | 713 |
|
|
2023
Q4 | $256K | Sell |
2,241
-89
| -4% | -$8.83K | 0.01% | 631 |
|
|
2023
Q3 | $208K | Buy |
2,330
+153
| +7% | +$13.4K | 0.01% | 654 |
|
|
2023
Q2 | $186K | Buy |
2,177
+34
| +2% | +$2.95K | 0.01% | 706 |
|
|
2023
Q1 | $238K | Sell |
2,143
-300
| -12% | -$34.6K | 0.01% | 605 |
|
|
2022
Q4 | $232K | Buy |
2,443
+89
| +4% | +$8.55K | 0.01% | 656 |
|
|
2022
Q3 | $233K | Hold |
2,354
| – | – | 0.01% | 627 |
|
|
2022
Q2 | $278K | Sell |
2,354
-90
| -4% | -$13.2K | 0.01% | 600 |
|
|
2022
Q1 | $488K | Sell |
2,444
-13,736
| -85% | -$3.05M | 0.02% | 547 |
|
|
2021
Q4 | $4.68M | Buy |
16,180
+1,242
| +8% | +$297K | 0.06% | 239 |
|
|
2021
Q3 | $2.68M | Sell |
14,938
-641
| -4% | -$108K | 0.04% | 375 |
|
|
2021
Q2 | $2.42M | Buy |
15,579
+505
| +3% | +$68.3K | 0.03% | 437 |
|
|
2021
Q1 | $2.04M | Buy |
15,074
+42
| +0.3% | +$5.11K | 0.03% | 507 |
|
|
2020
Q4 | $1.45M | Sell |
15,032
-97
| -0.6% | -$7.9K | 0.02% | 646 |
|
|
2020
Q3 | $1.22M | Sell |
15,129
-1,032
| -6% | -$81.6K | 0.02% | 628 |
|
|
2020
Q2 | $972K | Sell |
16,161
-2,369
| -13% | -$148K | 0.02% | 759 |
|
|
2020
Q1 | $1.07M | Sell |
18,530
-205
| -1% | -$13.9K | 0.02% | 646 |
|
|
2019
Q4 | $1.23M | Sell |
18,735
-931
| -5% | -$49.1K | 0.02% | 776 |
|
|
2019
Q3 | $786K | Sell |
19,666
-639
| -3% | -$21.6K | 0.01% | 1000 |
|
|
2019
Q2 | $592K | Buy |
20,305
+27
| +0.1% | +$881 | 0.01% | 1199 |
|
|
2019
Q1 | $806K | Sell |
20,278
-59
| -0.3% | -$2.33K | 0.01% | 1006 |
|
|
2018
Q4 | $757K | Sell |
20,337
-170
| -0.8% | -$6.38K | 0.02% | 954 |
|
|
2018
Q3 | $936K | Buy |
20,507
+178
| +0.9% | +$8.47K | 0.02% | 977 |
|
|
2018
Q2 | $1.02M | Buy |
20,329
+94
| +0.5% | +$4.26K | 0.02% | 912 |
|
|
2018
Q1 | $925K | Buy |
20,235
+391
| +2% | +$17.7K | 0.01% | 937 |
|
|
2017
Q4 | $793K | Sell |
19,844
-35,460
| -64% | -$1.36M | 0.01% | 1017 |
|
|
2017
Q3 | $2.17M | Sell |
55,304
-657
| -1% | -$29.6K | 0.01% | 916 |
|
|
2017
Q2 | $2.89M | Sell |
55,961
-586
| -1% | -$32K | 0.02% | 841 |
|
|
2017
Q1 | $2.8M | Sell |
56,547
-174
| -0.3% | -$9.35K | 0.02% | 847 |
|
|
2016
Q4 | $3.04M | Sell |
56,721
-645
| -1% | -$37.3K | 0.02% | 811 |
|
|
2016
Q3 | $3.36M | Sell |
57,366
-1,888
| -3% | -$104K | 0.02% | 745 |
|
|
2016
Q2 | $3.19M | Buy |
59,254
+1,356
| +2% | +$93.2K | 0.02% | 748 |
|
|
2016
Q1 | $4.62M | Buy |
57,898
+1,201
| +2% | +$91.1K | 0.04% | 551 |
|
|
2015
Q4 | $4.55M | Buy |
56,697
+785
| +1% | +$66.7K | 0.04% | 540 |
|
|
2015
Q3 | $4.61M | Buy |
55,912
+30,666
| +121% | +$2.32M | 0.03% | 545 |
|
|
2015
Q2 | $2.19M | Buy |
+25,246
| New | +$2.3M | 0.02% | 936 |
|
|
2015
Q1 | – | Sell |
-27,694
| Closed | -$1.91M | – | 2423 |
|
|
2014
Q4 | $1.91M | Hold |
27,694
| – | – | 0.01% | 986 |
|
|
2014
Q3 | $2.03M | Hold |
27,694
| – | – | 0.01% | 942 |
|
|
2014
Q2 | $2.51M | Buy |
27,694
+555
| +2% | +$37.6K | 0.02% | 895 |
|
|
2014
Q1 | $1.63M | Buy |
27,139
+1,546
| +6% | +$91.8K | 0.01% | 1073 |
|
|
2013
Q4 | $1.33M | Buy |
25,593
+620
| +2% | +$30.4K | 0.01% | 1167 |
|
|
2013
Q3 | $1.11M | Sell |
24,973
-1,132
| -4% | -$46.3K | 0.01% | 1226 |
|
|
2013
Q2 | $1.01M | Buy |
+26,105
| New | +$1.04M | 0.01% | 1227 |
|
Other funds holding SYNA
OAG
TI
Metropolitan Life Insurance Company (MetLife)'s SYNA Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Synaptics (SYNA) in Q2 2024, closing a stake of 2,075 shares — an estimated $202K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SYNA in Q2 2013 and held it in 43 quarters. The position peaked at $4.68M in Q4 2021. 264 funds tracked by Wall St. Rank hold SYNA as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Synaptics position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,075 Synaptics shares in Q2 2024, an estimated $202K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Synaptics in Q2 2013 and held it in 43 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Synaptics position peaked at $4.68M in Q4 2021.
- 264 funds tracked by Wall St. Rank held Synaptics as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.